-
1
-
-
84891878992
-
The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT
-
Marek A, Stern M, Chalandon Y, et al. The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT. Bone Marrow Transplant 2014; 49:55-61.
-
(2014)
Bone Marrow Transplant
, vol.49
, pp. 55-61
-
-
Marek, A.1
Stern, M.2
Chalandon, Y.3
-
2
-
-
84895924487
-
Looking for biological factors to predict the risk of active cytomegalovirus infection in nonimmunosuppressed critically ill patients
-
Bravo D, Clari MA, Aguilar G, et al. Looking for biological factors to predict the risk of active cytomegalovirus infection in nonimmunosuppressed critically ill patients. J Med Virol 2014; 86:827-833.
-
(2014)
J Med Virol
, vol.86
, pp. 827-833
-
-
Bravo, D.1
Clari, M.A.2
Aguilar, G.3
-
3
-
-
84905030074
-
Cytomegalovirus pneumonia in hematopoietic stem cell recipients
-
Travi G, Pergam SA. Cytomegalovirus pneumonia in hematopoietic stem cell recipients. J Intensive Care Med 2013; 29:200-212.
-
(2013)
J Intensive Care Med
, vol.29
, pp. 200-212
-
-
Travi, G.1
Pergam, S.A.2
-
4
-
-
33646589293
-
Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation
-
Loeffler J, Steffens M, Arlt EM, et al. Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation. J Clin Microbiol 2006; 44:1847-1850.
-
(2006)
J Clin Microbiol
, vol.44
, pp. 1847-1850
-
-
Loeffler, J.1
Steffens, M.2
Arlt, E.M.3
-
5
-
-
0037082494
-
Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after highdose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab
-
Goldberg SL, Pecora AL, Alter RS, et al. Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after highdose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood 2002; 99:1486-1488.
-
(2002)
Blood
, vol.99
, pp. 1486-1488
-
-
Goldberg, S.L.1
Pecora, A.L.2
Alter, R.S.3
-
6
-
-
84880842646
-
A messenger at the door: Cytomegalovirus retinitis in myeloma patients with progressive disease
-
Teh BW, Khot AS, Harrison SJ, et al. A messenger at the door: cytomegalovirus retinitis in myeloma patients with progressive disease. Transpl Infect Dis 2013; 15:E134-E138.
-
(2013)
Transpl Infect Dis
, vol.15
, pp. E134-E138
-
-
Teh, B.W.1
Khot, A.S.2
Harrison, S.J.3
-
7
-
-
84901796507
-
Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients
-
Hiwarkar P, Gajdosova E, Qasim W, et al. Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients. Clin Infect Dis 2014; 58:1700-1706.
-
(2014)
Clin Infect Dis
, vol.58
, pp. 1700-1706
-
-
Hiwarkar, P.1
Gajdosova, E.2
Qasim, W.3
-
8
-
-
0037438514
-
Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: Importance of viral load and T-cell immunity
-
Boeckh M, Leisenring W, Riddell SR, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 2003; 101:407-414.
-
(2003)
Blood
, vol.101
, pp. 407-414
-
-
Boeckh, M.1
Leisenring, W.2
Riddell, S.R.3
-
9
-
-
84905043824
-
Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: A study by the European group for blood and marrow transplantation
-
Ljungman P, Brand R, Hoek J, et al. Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation. Clin Infect Dis 2014; 59:473-481.
-
(2014)
Clin Infect Dis
, vol.59
, pp. 473-481
-
-
Ljungman, P.1
Brand, R.2
Hoek, J.3
-
10
-
-
84892480241
-
Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: A retrospective monocentre study on 547 patients
-
Venton G, Crocchiolo R, Fürst S, et al. Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patients. Clin Microbiol Infect 2014; 20:160-166.
-
(2014)
Clin Microbiol Infect
, vol.20
, pp. 160-166
-
-
Venton, G.1
Crocchiolo, R.2
Fu Rst, S.3
-
11
-
-
84901985882
-
The clinical and financial burden of preemptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventive treatment approaches
-
Jain NA, Lu K, Ito S, et al. The clinical and financial burden of preemptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventive treatment approaches. Cytotherapy 2014; 16:927-933.
-
(2014)
Cytotherapy
, vol.16
, pp. 927-933
-
-
Jain, N.A.1
Lu, K.2
Ito, S.3
-
12
-
-
84887151263
-
CMV reactivation after allogeneic HCT and relapse risk: Evidence for early protection in acute myeloid leukemia
-
Green ML, Leisenring WM, Xie H, et al. CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Blood 2013; 122:1316-1324.
-
(2013)
Blood
, vol.122
, pp. 1316-1324
-
-
Green, M.L.1
Leisenring, W.M.2
Xie, H.3
-
13
-
-
84887145602
-
CMV: A warrior against leukemia?
-
Ljungman P. CMV: a warrior against leukemia? Blood 2013; 22:1101-1102.
-
(2013)
Blood
, vol.22
, pp. 1101-1102
-
-
Ljungman, P.1
-
14
-
-
84872403604
-
CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients
-
Cardeñoso L, Pinsky BA, Lautenschlager I, et al. CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients. J Clin Virol 2013; 56:108-112.
-
(2013)
J Clin Virol
, vol.56
, pp. 108-112
-
-
Cardeñoso, L.1
Pinsky, B.A.2
Lautenschlager, I.3
-
15
-
-
0037090071
-
Definitions of cytomegalovirus infection and disease in transplant recipients
-
Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34:1094-1097.
-
(2002)
Clin Infect Dis
, vol.34
, pp. 1094-1097
-
-
Ljungman, P.1
Griffiths, P.2
Paya, C.3
-
16
-
-
78549241330
-
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
-
Feuchtinger T, Opherk K, Bethge WA, et al. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood 2010; 116:4360-4367.
-
(2010)
Blood
, vol.116
, pp. 4360-4367
-
-
Feuchtinger, T.1
Opherk, K.2
Bethge, W.A.3
-
17
-
-
79952470341
-
Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation
-
Schmitt A, Tonn T, Busch DH, et al. Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion 2011; 51:591-599.
-
(2011)
Transfusion
, vol.51
, pp. 591-599
-
-
Schmitt, A.1
Tonn, T.2
Busch, D.H.3
-
18
-
-
84887515875
-
Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?
-
Kekre N, Tokessy M, Mallick R, et al. Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction? Biol Blood Marrow Transplant 2013; 19:1719-1724.
-
(2013)
Biol Blood Marrow Transplant
, vol.19
, pp. 1719-1724
-
-
Kekre, N.1
Tokessy, M.2
Mallick, R.3
-
19
-
-
84878785114
-
Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients
-
Bacigalupo A, Boyd A, Slipper J, et al. Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients. Expert Rev Anti Infect Ther 2012; 10:1249-1264.
-
(2012)
Expert Rev Anti Infect Ther
, vol.10
, pp. 1249-1264
-
-
Bacigalupo, A.1
Boyd, A.2
Slipper, J.3
-
20
-
-
79953035666
-
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: A phase 3, double-blind, placebo-controlled, randomised trial
-
Marty FM, Ljungman P, Papanicolaou GA, et al. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial. Lancet Infect Dis 2011; 11:284-292.
-
(2011)
Lancet Infect Dis
, vol.11
, pp. 284-292
-
-
Marty, F.M.1
Ljungman, P.2
Papanicolaou, G.A.3
-
21
-
-
0028274678
-
Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group
-
Prentice HG, Gluckman E, Powles RL, et al. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet 1994; 343:749-753.
-
(1994)
Lancet
, vol.343
, pp. 749-753
-
-
Prentice, H.G.1
Gluckman, E.2
Powles, R.L.3
-
22
-
-
55849143692
-
Contemporary management of cytomegalovirus infection in transplant recipients: Guidelines from an IHMF workshop
-
Griffiths P, Whitley R, Snydman DR, et al. Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop. Herpes 2008; 15:4-12.
-
(2008)
Herpes
, vol.15
, pp. 4-12
-
-
Griffiths, P.1
Whitley, R.2
Snydman, D.R.3
-
23
-
-
84899819902
-
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation
-
Chemaly RF, Ullmann AJ, Stoelben S, et al. Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N Engl J Med 2014; 370:1781-1789.
-
(2014)
N Engl J Med
, vol.370
, pp. 1781-1789
-
-
Chemaly, R.F.1
Ullmann, A.J.2
Stoelben, S.3
-
24
-
-
44049085618
-
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study
-
Winston DJ, Young JA, Pullarkat V, et al. Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study. Blood 2008; 111:5403-5410.
-
(2008)
Blood
, vol.111
, pp. 5403-5410
-
-
Winston, D.J.1
Young, J.A.2
Pullarkat, V.3
-
25
-
-
84878608183
-
Maribavir use in practice for cytomegalovirus infection in French transplantation centers
-
Alain S, Revest M, Veyer D, et al. Maribavir use in practice for cytomegalovirus infection in French transplantation centers. Transplant Proc 2013; 45:1603-1607.
-
(2013)
Transplant Proc
, vol.45
, pp. 1603-1607
-
-
Alain, S.1
Revest, M.2
Veyer, D.3
-
26
-
-
84884528238
-
CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation
-
Marty FM, Winston DJ, Rowley SD, et al. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med 2013; 369:1227-1236.
-
(2013)
N Engl J Med
, vol.369
, pp. 1227-1236
-
-
Marty, F.M.1
Winston, D.J.2
Rowley, S.D.3
-
27
-
-
84886474257
-
Detection of cytomegalovirus drug resistance mutations by next-generation sequencing
-
Sahoo MK, Lefterova MI, Yamamoto F, et al. Detection of cytomegalovirus drug resistance mutations by next-generation sequencing. J Clin Microbiol 2013; 51:3700-3710.
-
(2013)
J Clin Microbiol
, vol.51
, pp. 3700-3710
-
-
Sahoo, M.K.1
Lefterova, M.I.2
Yamamoto, F.3
-
28
-
-
84905561856
-
Cytomegalovirus antiviral resistance: Characterization of results from clinical specimens
-
Kleiboeker S, Nutt J, Schindel B, et al. Cytomegalovirus antiviral resistance: characterization of results from clinical specimens. Transpl Infect Dis 2014; 16:561-567.
-
(2014)
Transpl Infect Dis
, vol.16
, pp. 561-567
-
-
Kleiboeker, S.1
Nutt, J.2
Schindel, B.3
-
29
-
-
84904884970
-
Lowest numbers of primary CD8+ T cells can reconstitute protective immunity upon adoptive immunotherapy
-
Stemberger C, Graef P, Odendahl M, et al. Lowest numbers of primary CD8+ T cells can reconstitute protective immunity upon adoptive immunotherapy. Blood 2014; 124:628-637.
-
(2014)
Blood
, vol.124
, pp. 628-637
-
-
Stemberger, C.1
Graef, P.2
Odendahl, M.3
-
30
-
-
84878908146
-
GdT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia
-
Scheper W, van Dorp S, Kersting S, et al. gdT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia. Leukemia 2013; 27:1328-1338.
-
(2013)
Leukemia
, vol.27
, pp. 1328-1338
-
-
Scheper, W.1
Van Dorp, S.2
Kersting, S.3
-
31
-
-
46349108117
-
Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects
-
Wloch MK, Smith LR, Boutsaboualoy S, et al. Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects. J Infect Dis 2008; 197:1634-1642.
-
(2008)
J Infect Dis
, vol.197
, pp. 1634-1642
-
-
Wloch, M.K.1
Smith, L.R.2
Boutsaboualoy, S.3
-
32
-
-
69849102119
-
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: A global perspective
-
Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15:1143-1238.
-
(2009)
Biol Blood Marrow Transplant
, vol.15
, pp. 1143-1238
-
-
Tomblyn, M.1
Chiller, T.2
Einsele, H.3
-
33
-
-
84859394806
-
Complications, diagnosis, management, and prevention of CMV infections: Current and future
-
Boeckh M. Complications, diagnosis, management, and prevention of CMV infections: current and future. Hematology Am Soc Hematol Educ Program 2011; 2011:305-309.
-
(2011)
Hematology Am Soc Hematol Educ Program
, vol.2011
, pp. 305-309
-
-
Boeckh, M.1
|